These innovative medications , Tirzepatide , represent a significant advancement in managing type 2 diabetes and potentially related ailments . They are grouped as GLP-1 hormone agonists , indicating they to mimic the endogenous GLP-1 hormone , stimulating metabolic release and reducing hunger . Despite Retatrutide each operates largely similarly,